The Motley Fool Discussion Boards

Previous Page

Investing/Strategies / New Paradigm Investing

URL:  http://boards.fool.com/denny-thanks-for-your-thoughtful-reply-i-may-have-23804587.aspx

Subject:  Re: Denny Date:  3/8/2006  8:24 AM
Author:  TAR12 Number:  26316 of 77894

Denny

Thanks for your thoughtful reply. I may have spent too much time analyzing ISRG, but the business concerns are not that much of a barrier to me. I am considering adding to my position (in at 40 last year). As to some of your concerns regarding price--this is not a barrier to sales; institutions such as hospitals will pay anything for equipment, and for those institutions that have surgeons asking for something--they spend the money. Additionally, the hospitals in major cities are competing to have these machines and are beginnning to advertise them. Additionally, the adoption rate of the technology is surprising to me-- almost 1 in 5 of the radical prostectomies (sorry if the procedure is misspelled) in 5 years? My only problems so far have been trying to determine the rate of recurring sales growth in relation to the installed base, but even if recurring revenue grows in direct line to installed sales, the growth is phenomenal-- but I believe that the recurring revenue will grow at a greater rate.
The forward P/E is hard to guess, but I think the increased revenue from sales will keep the forward P/E in line with present, despite taxes. Although seemingly high, the company still has 5X growth to corner the prostate market, with other surgical procedures to come on line in the next five years it will be interesting to watch.

Even with that said, I can see the share price drop after a slow 1st quarter earnings release. Following that, the next three quarters will surprise. Only time will tell, but 70 may be a better target after the next earnings release.

Thanks for FMD- I agree with your analysis on this as a purchase now, and will be looking to change some positions in May, and this is one that has been on my watch list since the discussions. Mor